Investing

Investing Cash Flow

Medtronic Investing Cash Flow decreased by 46.7% to -$719.00M in Q2 2025 compared to the prior quarter. Year-over-year, this metric declined by 177.6%, from -$259.00M to -$719.00M.

Analysis

StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026Aug 26, 2025

How to read this metric

A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.

Detailed definition

This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...

Peer comparison

Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.

Metric ID: net_cash_from_investing

Historical Data

14 periods
 Q1 '22Q2 '22Q1 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value-$784.00M-$1.95B-$1.59B-$2.06B-$475.00M-$539.00M-$65.00M-$1.07B-$696.00M-$259.00M-$942.00M-$246.00M-$490.00M-$719.00M
QoQ Change-148.3%+18.6%-29.7%+76.9%-13.5%+87.9%<-999%+34.7%+62.8%-263.7%+73.9%-99.2%-46.7%
YoY Change-102.2%+66.0%+48.1%-46.5%+51.9%<-999%+76.9%+29.6%-177.6%
Range-$2.06B-$65.00M
CAGR-2.6%
Avg YoY Growth-155.9%
Median YoY Growth+29.6%
Current Streak2 quarters decline

Frequently Asked Questions

What is Medtronic's investing cash flow?
Medtronic (MDT) reported investing cash flow of -$719.00M in Q2 2025.
How has Medtronic's investing cash flow changed year-over-year?
Medtronic's investing cash flow decreased by 177.6% year-over-year, from -$259.00M to -$719.00M.
What does investing cash flow mean?
The net amount of cash spent on or received from investing activities.